Audited Report & Accounts published on website

ImmuPharma PLC (LSE:IMM), (“ImmuPharma” or the “Company”), the specialist drug discovery and development company confirms that the Audited Annual Report and Accounts (“Report”) for the year ended 31 December 2019, has today been published on the Company’s website. Copies of this Report, including the Notice of Annual General Meeting, will be posted to shareholders in the near future.

Confirmation of this date will be announced to the market on the day of posting. To view the Report please go to: www.immupharma.co.uk